ALGIPHARMA UK LIMITED

🏛️Establishedactive
10794468 · ltd · incorporated 2017-05-30
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
Upgrade to see
Turnover
year to May 2025
Net worth
book net assets
Opportunity
77/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: SIC 21200
Sector: Manufacturing
Investor take
Pursue
Active trading company with a 67-year-old founder — textbook succession opportunity.

Opportunity 77/100 (strong), bankability 75/100. Strong seller-intent signal (60/100, director aged 67). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
Network not yet resolved
30
Filing history
18 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
77/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
65
Adequate — check latest filings for context.
Acquirability
75
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0May 2024May 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2025-05-312024-05-31

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

Recent activity

Last 30 days
1
filing
  • 1 confirmation-statement
Last 90 days
1
filing
  • 1 confirmation-statement
Last 180 days
2
filings
  • 1 confirmation-statement
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (12 events)Click to expand
  1. 2026-01-27
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  2. 2025-02-18
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  3. 2024-02-05
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  4. 2023-02-02
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  5. 2022-02-08
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  6. 2021-05-26
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  7. 2020-02-06
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  8. 2019-01-24
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  9. 2017-05-30
    🏢
    Company incorporated
    As ALGIPHARMA UK LIMITED
  10. 2017-05-30
    DESSEN, Arne, Mr. appointed
    director
  11. 2017-05-30
    RYE, Philip Desmond, Dr. appointed
    director
  12. 2017-05-30
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

78/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Founder age: Director aged approximately 67 — succession pressure is live.
  • +No director turnover: Company is 9 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

56/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 67. Approaching typical UK retirement age — succession thinking likely.
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Group structure

Algipharma As is the ultimate parent — holding 75%+ shares. This company sits inside their group.

🏛️
Algipharma As
Corporate parent · holds 75-100% shares
ultimate parent
ALGIPHARMA UK LIMITED
This company · 10794468

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Algipharma As
Corporate entity
75100%
75-100% shares30/05/2017

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Manufacturing · CF postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
A&N PRINT LIMITED
06699046 · est 2008 · no financials extracted
17y
ALIZE SHUTTERS CURTAINS & BLINDS LTD
13307450 · est 2021 · no financials extracted
5y
ALJAMRY ENGINEERING LIMITED
13859093 · est 2022 · no financials extracted
4y
ALL PLANT OPERATOR AND REPAIR SERVICES LIMITED
13455393 · est 2021 · no financials extracted
4y
ALLBELT (SOUTH WALES) LTD
07299394 · est 2010 · no financials extracted
15y
ALLEN AND COMPANY (INDUSTRIAL GLAZING AND PAINTING SPECIALISTS) LIMITED
01508681 · est 1980 · no financials extracted
45y
ALLEN CHRISTOPHER WELDING LIMITED
06767524 · est 2008 · no financials extracted
17y
ALLENS PRINTERS LIMITED
00877370 · est 1966 · no financials extracted
59y
ALLOYGUYS LIMITED
16299096 · est 2025 · no financials extracted
1y
ALPHA PIPELINES LIMITED
06731349 · est 2008 · no financials extracted
17y
ALROD LIMITED
02020301 · est 1986 · no financials extracted
39y
ALTERATIONS SUITE LTD
15677071 · est 2024 · no financials extracted
1y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2017-05-30
Jurisdictionengland-wales
Primary SIC21200 — SIC 21200

Registered office

The Maltings East Tyndall Street
Cardiff Bay
Cardiff
CF24 5EA
Wales

Filing status

Accounts
Next due: 2027-02-28
Last made up to: 2025-05-31
Confirmation statement
Next due: 2027-06-12
Last: 2026-05-29

Officers (2 active · 0 resigned)

DESSEN, Arne, Mr.
director · ~67y · appointed 2017-05-30
View their other companies + combined net worth →
Active
RYE, Philip Desmond, Dr.
director · ~64y · appointed 2017-05-30
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (18 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-06-08
accounts-with-accounts-type-dormant
accounts · AA
2026-01-27
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-05-30
accounts-with-accounts-type-dormant
accounts · AA
2025-02-18
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-05-30
accounts-with-accounts-type-dormant
accounts · AA
2024-02-05
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-05-30
accounts-with-accounts-type-dormant
accounts · AA
2023-02-02
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-06-03
accounts-with-accounts-type-dormant
accounts · AA
2022-02-08
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-06-02
accounts-with-accounts-type-dormant
accounts · AA
2021-05-26
confirmation-statement-with-no-updates
confirmation-statement · CS01
2020-06-02
accounts-with-accounts-type-dormant
accounts · AA
2020-02-06
confirmation-statement-with-no-updates
confirmation-statement · CS01
2019-06-03